{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:23:58Z","timestamp":1790029438752,"version":"4.0.1"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan","award":["(No. 25460444)"],"award-info":[{"award-number":["(No. 25460444)"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To analyse the clinicopathological characteristics and prognosis of 40 rheumatoid arthritis (\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      ) patients with methotrexate (\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      )\u2010associated large B cell lymphoproliferative disorders (\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      Soluble interleukin 2 receptor titres (median 1500\u00a0U\/ml) in 40 patients with\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      were lower than those of 24\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      patients with non\u2010\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2010 associated (non\u2010\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      )\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      (5731\u00a0U\/ml) and 15 with control diffuse large B cell lymphoma (\n                      <jats:styled-content style=\"fixed-case\">DLBCL<\/jats:styled-content>\n                      , 5918\u00a0U\/ml) (\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.01). Using\n                      <jats:italic>in\u2010situ<\/jats:italic>\n                      hybridization, Epstein\u2013Barr virus (\n                      <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\n                      ) was detected in tumour cells of 25 of 40\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      patients with\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      (63%). Immunohistologically,\n                      <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>\n                      2 expression was detected in 35% of patients with\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      , which was lower than 93% of control\n                      <jats:styled-content style=\"fixed-case\">DLBCL<\/jats:styled-content>\n                      patients (\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.01). Eleven patients with\n                      <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\n                      <jats:sup>+<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      (44%) showed remission after\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      withdrawal. In\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      patients with clinical stage\n                      <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">IV BLPD<\/jats:styled-content>\n                      , 15 with rituximab (R)+ cytotoxic therapies pursued better prognosis than 10 with R\u2212 cytotoxic therapies (\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.05). Among the 15 patients, seven with\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      showed better overall survival than nine control\n                      <jats:styled-content style=\"fixed-case\">DLBCL<\/jats:styled-content>\n                      patients (\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In\n                      <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>\n                      patients with\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">BLPD<\/jats:styled-content>\n                      , immunosuppression by\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>\n                      infection and low\n                      <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content>\n                      2 expression in tumour cells may play roles in tumorigenesis and tumour regression. R+ cytotoxic therapies as well as\n                      <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>\n                      withdrawal were highly effective in these patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/his.12627","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T12:03:14Z","timestamp":1417176194000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate\u2010associated large B lymphoproliferative disorders"],"prefix":"10.1111","volume":"67","author":[{"given":"Kozue","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Pathology Faculty of Medicine Fukuoka University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Oshiro","sequence":"additional","affiliation":[{"name":"Department of Pathology Matsuyama Red Cross Hospital Matsuyama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Clinical Research Center National Hospital Organization Kyushu Medical Center Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Fujisaki","sequence":"additional","affiliation":[{"name":"Department of Hematology Matsuyama Red Cross Hospital Matsuyama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Clinical Research Center National Hospital Organization Kyushu Medical Center Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifuku","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Pathology Clinical Research Center National Hospital Organization Kyushu Medical Center Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Suematsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Clinical Research Center National Hospital Organization Kyushu Medical Center Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Hematology and Infectious Disease Department of Internal Medicine Faculty of Medicine Fukuoka University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morishige","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Pathology Faculty of Medicine Fukuoka University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2404"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01564.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3909"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281806"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-008-9069-8"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-013-1389-1"},{"key":"e_1_2_7_10_1","first-page":"350","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Gaulard P","year":"2008"},{"key":"e_1_2_7_11_1","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida Y","year":"2007","journal-title":"J. Rheumatol."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181cf8622"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01517.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.10.038"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02207682"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213317.59176.d2"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.5450"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh313"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200301000-00003"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.52"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098169"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21003"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000282"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/PDM.0b013e31804f54a9"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11360"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4521"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhis.12627","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.12627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:42:56Z","timestamp":1696290176000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.12627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1111\/his.12627"],"URL":"https:\/\/doi.org\/10.1111\/his.12627","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]},"assertion":[{"value":"2014-07-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-02-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}